#USA #Boston #Market Growth #biotechnology #Protein Synthesis

BCC Research Unveils the 2024 Protein Synthesis Research Review

BOSTON, July 9, 2025 – BCC Research has published its "2024 Protein Synthesis Research Review," delivering a thorough examination of the expanding protein synthesis market. This comprehensive report provides valuable insights into market trends, growth forecasts, and the pioneering companies that are shaping the field.

Key Highlights from the Research Review

The report outlines several significant segments within the protein synthesis industry, detailing their projected growth:

1. Commercial Amino Acids Market: Expected to increase from $31.8 billion in 2024 to $42.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%.
2. Recombinant Proteins Market: Anticipated growth from $141.8 billion in 2024 to $203.6 billion by 2029, supported by a CAGR of 7.5%.
3. PEGylated Proteins Market: Predicted to rise from $10.2 billion in 2023 to $15.9 billion by 2028, reflecting a robust CAGR of 9.4%.

Overview of Protein Synthesis

Protein synthesis is a vital biological process essential for the functioning of all living organisms, allowing cells to manufacture proteins necessary for various functions and survival. The principal components driving this process include:

• - DNA and RNA: Genetic blueprints guiding protein assembly.
• - Ribosomes: Molecular machines facilitating protein construction.
• - Amino Acids: Building blocks combining to form proteins.

Market Drivers

The escalation in the prevalence of chronic diseases is prompting an increased demand for protein therapeutics, which in turn is fueling market expansion. Moreover, innovations in cell-free systems and the development of improved expression vectors are enhancing production efficiencies and stoking further growth.

Technological Developments

Recent advancements in the field have underscored key technological trends, including:

• - Cell-Free Systems: Enabling more efficient protein production processes.
• - High-Throughput Technologies: Accelerating research and application in various sectors.
• - Personalized Medicine: Tailoring therapeutic approaches to individual patient needs.

Despite these advancements, the sector faces challenges, particularly in relation to high production costs and the complexities associated with various protein synthesis techniques.

Key Players Driving the Market

Significant contributors in the protein therapeutics arena include leading firms such as:

• - Amgen Inc.
• - Pfizer Inc.
• - Genentech USA Inc.
• - Eli Lilly

Meanwhile, research and development-focused companies are making strides in protein synthesis innovations, including:

• - GenScript ProBio
• - Aldevron
• - Creative Biogene
• - Tierra Biosciences Inc.

Research Summary

The comprehensive 2024 Protein Synthesis Research Review exemplifies the high-value quantitative data and insightful analysis BCC Research has consistently delivered since its inception in 1971. The report consolidates highlights from various studies conducted in 2024, including:

• - BIO007N: Commercial Amino Acids Market.
• - BIO254A: Global Recombinant Proteins Market.
• - BIO220B: Oligonucleotides Global Markets.
• - BIO253A: PEGylated Proteins Market.
• - BIO252A: Peptide Synthesis Global Markets.

This review encapsulates significant findings from multiple avenues of BCC Research’s ongoing investigations, encouraging readers to consult the full studies for comprehensive insights.

For further information regarding these reports or to make a purchase, reach out to [email protected]

About BCC Research

BCC Research specializes in delivering quantitative market evaluations, aiming to equip clients with objective insights necessary for informed business decision-making, devoid of hype or uncertainty.

For media inquiries, please contact [email protected] For access to our expansive market research library, visit our media page.

Like any data sourced from this press release, proper attribution to BCC Research LLC as the originator is essential.